IL-1β polymorphism in COPD patients in Turkish population

Area of Science:

• Genetics
• Respiratory Medicine
• Immunology

Background:

• Chronic obstructive pulmonary disease (COPD) involves airway inflammation linked to noxious stimuli.
• Interleukin-1 beta (IL-1β), a key pro-inflammatory cytokine, has shown controversial associations with COPD.
• Investigating IL-1β gene polymorphisms may elucidate its role in COPD development.

Purpose of the Study:

• To examine the association between IL-1β gene polymorphisms (rs 16944 and rs 1143634) and COPD.
• To analyze genotype, allele, and haplotype distributions in a Turkish population.

Main Methods:

• A case-control study involving 152 participants: 72 COPD patients, 41 healthy smokers, and 39 never-smokers.
• Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) was employed.
• Allele, genotype, and haplotype frequencies were determined.

Main Results:

• No statistically significant differences were observed in genotype frequencies or haplotype associations between COPD patients and controls.
• The study found no significant association between IL-1β polymorphisms and COPD, regardless of disease stage, gender, or smoking status.

Conclusions:

• The findings do not support a link between IL-1β -511 (rs 16944) and +3954 (rs 1143634) gene polymorphisms and COPD in the studied Turkish population.
• The precise role of IL-1β in COPD pathogenesis requires further investigation.